Kamat AM - Search Results

1

Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1.

Hensley PJ, Seiler R, Herr H, Mouw KW, Iyer G, Dyrskjøt L, Nawroth R, Goebell P, Schmitz-Drager B, Todenhofer T, Black PC, Kamat AM, Williams SB. Hensley PJ, et al. Among authors: kamat am. Urol Oncol. 2023 Jul;41(7):307-312. doi: 10.1016/j.urolonc.2023.01.001. Epub 2023 Jan 25. Urol Oncol. 2023. PMID: 36702704 Review.

2

Diffuse granulomatous mesenteric disease caused by intravesical bacillus Calmette-Guérin instillation masquerading as peritoneal carcinomatosis.

Shapiro A, Vakar F, Kamat AM. Shapiro A, et al. Among authors: kamat am. Urol Oncol. 2005 Sep-Oct;23(5):352-3. doi: 10.1016/j.urolonc.2005.04.004. Urol Oncol. 2005. PMID: 16144670

3

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Among authors: kamat am. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

4

Review of the M.D. Anderson experience in the treatment of bladder sarcoma.

Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, Czerniak B, Kamat AM, Dinney CP, Grossman HB. Spiess PE, et al. Among authors: kamat am. Urol Oncol. 2007 Jan-Feb;25(1):38-45. doi: 10.1016/j.urolonc.2006.02.003. Urol Oncol. 2007. PMID: 17208137

5

Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.

Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, Lin DW. Wright JL, et al. Among authors: kamat am. J Urol. 2007 Dec;178(6):2302-6; discussion 2307. doi: 10.1016/j.juro.2007.08.038. Epub 2007 Oct 15. J Urol. 2007. PMID: 17936803

6

Considerations on the use of diagnostic markers in management of patients with bladder cancer.

Agarwal PK, Black PC, Kamat AM. Agarwal PK, et al. Among authors: kamat am. World J Urol. 2008 Feb;26(1):39-44. doi: 10.1007/s00345-007-0232-1. Epub 2007 Dec 19. World J Urol. 2008. PMID: 18092171 Review.

7

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA, Pisters L, Grossman HB, Dinney CP, Kamat AM. Kassouf W, et al. Among authors: kamat am. J Clin Oncol. 2008 Jan 1;26(1):121-6. doi: 10.1200/JCO.2007.12.9247. J Clin Oncol. 2008. PMID: 18165646

8

Malignant transformation of testicular teratoma: a chemoresistant phenotype.

Spiess PE, Pisters LL, Liu P, Pettaway CA, Kamat AM, Gomez JA, Tannir NM. Spiess PE, et al. Among authors: kamat am. Urol Oncol. 2008 Nov-Dec;26(6):595-9. doi: 10.1016/j.urolonc.2007.07.013. Epub 2008 Jan 14. Urol Oncol. 2008. PMID: 18367105 Free PMC article.

9

Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer.

Inamoto T, Shah JB, Kamat AM. Inamoto T, et al. Among authors: kamat am. Urol Oncol. 2009 Nov-Dec;27(6):585-91. doi: 10.1016/j.urolonc.2008.11.002. Epub 2009 Jan 22. Urol Oncol. 2009. PMID: 19162510 Review.

10

The role of radical cystectomy in patients with clinical T4b bladder cancer.

Black PC, Dinney CP, Brown GA, Kassouf W, Siefker-Radtke AO, Munsell MF, Grossman HB, Kamat AM. Black PC, et al. Among authors: kamat am. Urol Oncol. 2011 Mar-Apr;29(2):157-61. doi: 10.1016/j.urolonc.2009.12.015. Epub 2010 Apr 24. Urol Oncol. 2011. PMID: 20456984 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

493 results

Search Page